DLAT antibody

Catalog No. ABIN7249073

Product Details anti-DLAT Antibody

Target: DLAT (Dihydrolipoyl Transacetylase (DLAT))

Reactivity: Human, Mouse, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This DLAT antibody is un-conjugated

Application: Immunohistochemistry (IHC), ELISA

Characteristics: Polyclonal Antibody

Purification: Affinity purification

Immunogen: Fusion protein of human DLAT

Isotype: IgG

Application Details

Application Notes: IHC 1:30-150, ELISA 1:2000-5000

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.6 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Avoid freeze / thaw cycles.

Target Details for DLAT

Target: DLAT (Dihydrolipoyl Transacetylase (DLAT))

Alternative Name: DLAT (DLAT Products)

Synonyms: DLAT antibody, Dmel\\CG5261 antibody, EP(2)0816 antibody, EP816 antibody, anon-WO0118547.121 antibody, DLTA antibody, PDC-E2 antibody, PDCE2 antibody, wu:fc14f10 antibody, wu:fc21f08 antibody, wu:fc86g11 antibody, wu:fj57d06 antibody, 6332404G05Rik antibody, midline uncoordinated antibody, dihydrolipoamide S-acetyltransferase L homeolog antibody, dihydrolipoamide S-acetyltransferase antibody, dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex) antibody, muc antibody, dlat.L antibody, DLAT antibody, Dlat antibody, dlat antibody

Background: This gene encodes component E2 of the multi-enzyme pyruvate dehydrogenase complex (PDC). PDC resides in the inner mitochondrial membrane and catalyzes the conversion of pyruvate to acetyl coenzyme A. The protein product of this gene, dihydrolipoamide acetyltransferase, accepts acetyl groups formed by the oxidative decarboxylation of pyruvate and transfers them to coenzyme A. Dihydrolipoamide acetyltransferase is the antigen for antimitochondrial antibodies. These autoantibodies are present in nearly 95 % of patients with the autoimmune liver disease primary biliary cirrhosis (PBC). In PBC, activated T lymphocytes attack and destroy epithelial cells in the bile duct where this protein is abnormally distributed and overexpressed. PBC enventually leads to cirrhosis and liver failure. Mutations in this gene are also a cause of pyruvate dehydrogenase E2 deficiency which causes primary lactic acidosis in infancy and early childhood.

Molecular Weight: 69 kDa

UniProt: P10515